Healthcare Investors: Make AI your priority at the 38th Annual J.P. Morgan Healthcare Conference
Connect with AllazoHealth, January 13–16, 2020
Westin St. Francis Hotel | San Francisco, California
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, with over 9,000 total attendees and 450+ private and public companies. It brings together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
AI is the next frontier in improved patient adherence outcomes. And AllazoHealth has already arrived!
Our randomized control trial with Blue Cross Blue Shield of North Carolina generated 5.45 times the uplift in adherence compared to traditionally targeted interventions.
AllazoHealth uses AI to help pharmacies, payers and pharmaceuticals intelligently drive their outreach programs to improve adherence. We identify behavioral risk for individual patients, and provide specific and effective interventions.
As an healthcare investor, there is no better time than now to join us as we revolutionize the way our enterprise healthcare customers engage with and improve the health of their patient populations. To date, our customers already include some of the nation’s largest payers, pharmaceuticals, retail pharmacies, and provider systems.
Interested in learning more? Set aside some time at the J.P. Morgan Healthcare Conference to meet up with AllazoHealth.
AllazoHealth is a healthcare AI solution that uplifts adherence by predicting individual patient behavior and specifying personalized interventions. Our mission is to be the leader in precision engagement and predictive analytics, revolutionizing the way our healthcare clients improve the health of their patient populations.